Get the Stockscreener App
1.98
3.41%
-0.07
Alector Inc stock is traded at $1.98, with a volume of 37,879.
It is down -3.41% in the last 24 hours and down -1.49% over the past month.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
See More
Previous Close:
$2.05
Open:
$2
24h Volume:
37,879
Relative Volume:
0.04
Market Cap:
$218.52M
Revenue:
$21.05M
Net Income/Loss:
$-142.93M
P/E Ratio:
-1.425
EPS:
-1.3895
Net Cash Flow:
$-184.07M
1W Performance:
-11.21%
1M Performance:
-1.49%
6M Performance:
-34.65%
1Y Performance:
+48.87%
1-Day Range:
$1.96
$2.07
1-Week Range:
$1.96
$2.325
52-Week Range:
$0.87
$3.3999
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.98 | 226.24M | 21.05M | -142.93M | -184.07M | -1.3895 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.48 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
743.04 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
685.06 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.85 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.42 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-26 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-22-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-22-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-22-25 | Downgrade | Mizuho | Outperform → Neutral |
| Oct-22-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-28-25 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Rate Hike: What is the dividend yield of Alector IncBull Run & Breakout Confirmation Alerts - baoquankhu1.vn
Alector (ALEC) Reports Q2 Loss, Tops Revenue Estimates - MSN
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Alector, Inc. (NASDAQ:ALEC) Given Average Rating of "Hold" by Brokerages - MarketBeat
ALEC SEC FilingsAlector 10-K, 10-Q, 8-K Forms - Stock Titan
Alector (ALEC) CEO awarded 116,246 RSUs, boosts direct share stake - Stock Titan
Alector (ALEC) CFO granted 54,600 RSUs, holdings rise to 399,260 shares - Stock Titan
Stock Recap: What is the dividend yield of Alector IncMarket Volume Report & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Insider Sell Alert: Grace Wong-sarad Sells Shares of Alector Inc (ALEC) - GuruFocus
Alector (ALEC) officer sells 1,000 shares under 10b5-1 plan - Stock Titan
Alector (NASDAQ: ALEC) files shelf to offer up to $400M, includes $308.2M unsold - Stock Titan
Alector Stock Jumps On Upgrade, But AL101 Interim Data Will Be Key (NASDAQ:ALEC) - Seeking Alpha
Grace Wong-Sarad reports multiple ALEC share sales (NASDAQ: ALEC) - Stock Titan
BTIG upgrades Alector (ALEC) - MSN
Alector (ALEC) Shares Surge After Strategic Shift and Analyst Up - GuruFocus
Alector stock upgraded at BTIG (ALEC:NASDAQ) - Seeking Alpha
Alector, Inc. (ALEC) Receives Buy Rating With Promising Upside Potential From BTIG - 富途牛牛
Alector (ALEC)'s Technical Outlook is Bright After Key Golden Cross - Finviz
Wall Street Turns Bullish on HIMS, TDOC and ALEC as Partnerships Reshape Risk Profiles - AOL.com
Alector Inc (ALEC) Stock News & Articles - 24/7 Wall St.
Alector stock rating upgraded to Buy at BTIG on BBB-shuttle focus - Investing.com Australia
Alector (NASDAQ:ALEC) Stock Rating Upgraded by BTIG Research - MarketBeat
This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Alector stock rating upgraded to Buy at BTIG on BBB-shuttle focus By Investing.com - Investing.com India
Analyst BTIG Upgrades Alector (ALEC) to 'Buy' with a New Price T - GuruFocus
Alector (ALEC) Receives Upgrade: A Shift in Focus to Neurodegenerative Therapies - GuruFocus
Aug EndMonth: Is Alector Inc. undervalued by DCF analysis2026 Pullbacks & Safe Entry Zone Tips - baoquankhu1.vn
Street Watch: Is Alector Inc a cyclical or defensive stock2025 Earnings Impact & Community Trade Idea Sharing Platform - baoquankhu1.vn
How The Alector (ALEC) Story Is Shifting As Analyst Targets And Sector Views Evolve - Yahoo Finance
Alector Showcases ABC Brain-Delivery Platform, AL137 and AL050 Updates at TD Cowen Conference - Yahoo Finance
Insider Sell: Grace Wong-sarad Sells Shares of Alector Inc (ALEC) - GuruFocus
Alector at TD Cowen Conference: Advancing Brain Therapeutics By Investing.com - Investing.com Canada
Alector at TD Cowen Conference: Advancing Brain Therapeutics - Investing.com South Africa
Alector (ALEC) accounting chief sells 3,367 shares under 10b5-1 plan - Stock Titan
Alector (ALEC) accounting officer sells shares to cover RSU tax bill - Stock Titan
RSU tax sale: Alector (NASDAQ: ALEC) CEO sells 81,864 shares - Stock Titan
Alector (ALEC) CFO sells 29,649 shares to cover RSU tax obligations - Stock Titan
HC Wainwright Estimates Alector FY2030 Earnings - MarketBeat
ALEC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Alector (NASDAQ:ALEC) Stock Rating Lowered by Wall Street Zen - MarketBeat
Analysts Have Conflicting Sentiments on These Healthcare Companies: Xenon (XENE), Alector (ALEC) and Caris Life Sciences, Inc. (CAI) - The Globe and Mail
Neil Berkley sale 37,261 shares; ALEC (NASDAQ: ALEC) RSUs vest 45,520 - Stock Titan
Alector (NASDAQ:ALEC) Insider Grace Wong-Sarad Sells 4,079 Shares - MarketBeat
Alector (ALEC) Posts Steep US$37 Million Quarterly Loss Testing Bullish Pipeline Narratives - simplywall.st
Alector (ALEC) accounting chief sells 4,079 shares via 10b5-1 plan - Stock Titan
[144] Alector, Inc. SEC Filing - Stock Titan
Analysts Conflicted on These Healthcare Names: Alector (ALEC), Agilon Health (AGL) and Pennant Group (PNTG) - The Globe and Mail
Alector earnings beat by $0.05, revenue topped estimates - Investing.com Canada
Alector (ALEC) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Alector (NASDAQ:ALEC) Announces Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
Alector Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):